SOLICITATION NOTICE
66 -- Covaris S220 High Performance Ultrasonicator
- Notice Date
- 8/22/2011
- Notice Type
- Presolicitation
- NAICS
- 333314
— Optical Instrument and Lens Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-110167-LG
- Archive Date
- 9/21/2011
- Point of Contact
- Laura Glockner, Phone: 3014968607
- E-Mail Address
-
laura.glockner@nih.gov
(laura.glockner@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Room 6070, Rockville, MD, 20852, UNITED STATES Description The National Cancer Institute (NCI), Center for Cancer Research (CCR), Neuro-Oncology Branch plans to procure on a sole source basis the brand name S220 High Performance Ultrasonicator from Covaris, Inc., 14 Gill Street, Unit H, Woburn, MA 01801-1721. The supplies herein are being procured in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1 (b) (1). The North American Industry Classification System code is 333314 and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The delivery date shall be 45 days from date of award. The Neuro-Oncology Branch (NOB) is performing translational research on brain tumors, especially on the most malignant form - glioblastoma, using biological, biochemical, pathological, and immunological methods, to develop novel molecular therapeutics for patients with brain tumors. One of the on-going research projects within the laboratory is the Glioma Molecular Diagnostic Initiative (GMDI). Genomic profiling is the technique of looking at copy changes across the entire chromosome and performing a linear plot across the chromosome in a Megabase resolution. One of the critical steps for DNA sequencing is high quality DNA fragments in which the high performance ultrasonicator is a necessary powerful tool. Accordingly, the Neuro-Oncology Branch is procuring the S220 High Performance Ultrasonicator from Covaris, Inc., the sole manufacturer of the S220 High Performance Ultrasonicator, and the sole distributor in the USA. The Covaris technological foundation is based on its proprietary and patented AFA technology. The AFA technology enables a vast array of non-contact, isothermal processes to be developed, for use in a broad range of applications in Genomics, Proteomics, Cell Biology, and Drug Discovery research. In many cases, the ability to impart both thermal and non-contact control of application processes could not be obtained prior to the development of the AFA technology which gives the Covaris system truly sustainable competitive advantages. The following salient characteristics apply to the S220 High Performance Ultrasonicator from Covaris, Inc.: 1. Controllable time and acoustic energy transfer, and real-time monitored temperature, to ensure sample-to-sample reproducibility. 2. User-tunable, generated fragment size distribution (range: 100-bp to 5-kbp) 3. Closed tube, non contact process producing a controlled focused acoustic field inside a closed vessel. This is essential to limit sample cross-contamination and attendant contamination by human pathogens. The focused field allows for faster, continuous sample treatment, whereas with unfocused devices, longer treatment times result in introduction of significant heat into the system and are unable to be operated isothermally. 4. The system frequency must be within the ultrasonic range (500KHz and above, with wavelengths on average less than 1mm in length), and thus outside the human audible range. This is essential so that the instrument can be operated in a general laboratory bench setting without extra expense for system enclosures to ensure proper ear protection. 5. Sample input flexibility: tubes, vials, for single sample processing; and sample shearing, solubilization/disruption or extraction applications. 6. The maximum system size cannot exceed 21 cm wide x 52 cm deep owing to space limitations. 7. System does not require hearing protection or segregation from the common laboratory environment. This notice is not a request for a competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 11:00 AM EST, on September 6, 2011. For further information, please contact Laura Glockner, Contract Specialist via electronic mail at laura.glockner@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference: NCI-110167-LG on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-110167-LG/listing.html)
- Record
- SN02544875-W 20110824/110823000033-168f0bb46e708d175533a1807ad1522b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |